JP2020527597A5 - - Google Patents

Download PDF

Info

Publication number
JP2020527597A5
JP2020527597A5 JP2020515831A JP2020515831A JP2020527597A5 JP 2020527597 A5 JP2020527597 A5 JP 2020527597A5 JP 2020515831 A JP2020515831 A JP 2020515831A JP 2020515831 A JP2020515831 A JP 2020515831A JP 2020527597 A5 JP2020527597 A5 JP 2020527597A5
Authority
JP
Japan
Prior art keywords
alkyl
carbocyclyl
compound
substituted
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020515831A
Other languages
English (en)
Japanese (ja)
Other versions
JP7281822B2 (ja
JP2020527597A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/034724 external-priority patent/WO2018218192A1/en
Publication of JP2020527597A publication Critical patent/JP2020527597A/ja
Publication of JP2020527597A5 publication Critical patent/JP2020527597A5/ja
Priority to JP2022139960A priority Critical patent/JP2022169800A/ja
Application granted granted Critical
Publication of JP7281822B2 publication Critical patent/JP7281822B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020515831A 2017-05-26 2018-05-25 細菌の排出ポンプ阻害剤 Active JP7281822B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022139960A JP2022169800A (ja) 2017-05-26 2022-09-02 細菌の排出ポンプ阻害剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762511851P 2017-05-26 2017-05-26
US62/511,851 2017-05-26
US201762523156P 2017-06-21 2017-06-21
US62/523,156 2017-06-21
PCT/US2018/034724 WO2018218192A1 (en) 2017-05-26 2018-05-25 Bacterial efflux pump inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022139960A Division JP2022169800A (ja) 2017-05-26 2022-09-02 細菌の排出ポンプ阻害剤

Publications (3)

Publication Number Publication Date
JP2020527597A JP2020527597A (ja) 2020-09-10
JP2020527597A5 true JP2020527597A5 (https=) 2021-07-26
JP7281822B2 JP7281822B2 (ja) 2023-05-26

Family

ID=64395990

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020515831A Active JP7281822B2 (ja) 2017-05-26 2018-05-25 細菌の排出ポンプ阻害剤
JP2022139960A Pending JP2022169800A (ja) 2017-05-26 2022-09-02 細菌の排出ポンプ阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022139960A Pending JP2022169800A (ja) 2017-05-26 2022-09-02 細菌の排出ポンプ阻害剤

Country Status (5)

Country Link
US (1) US11826357B2 (https=)
EP (1) EP3630109A4 (https=)
JP (2) JP7281822B2 (https=)
CN (1) CN111163774A (https=)
WO (1) WO2018218192A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10836706B2 (en) 2016-02-24 2020-11-17 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
US10556854B2 (en) 2016-02-24 2020-02-11 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
US11938114B2 (en) 2017-03-10 2024-03-26 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
WO2018165612A1 (en) 2017-03-10 2018-09-13 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
CN110770224B (zh) 2017-03-10 2022-11-18 罗格斯新泽西州立大学 作为外排泵抑制剂的吲哚衍生物
EP3630109A4 (en) 2017-05-26 2021-03-17 Rutgers, the State University of New Jersey BACTERIAL EFFLUX PUMP INHIBITORS
WO2019005841A1 (en) 2017-06-26 2019-01-03 Rutgers, The State University Of New Jersey THERAPEUTIC COMPOUNDS AND METHODS FOR TREATING INFECTION
US11845742B2 (en) 2017-11-14 2023-12-19 Rutgers, The State University Of New Jersey Therapeutic compounds and methods to treat infection
WO2021203014A1 (en) 2020-04-03 2021-10-07 Vertex Pharmaceuticals Incorporated Pyrano[4,3-b]l ndole derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd)
US20240239771A1 (en) * 2020-05-29 2024-07-18 Taxis Pharmaceuticals, Inc. Bacterial efflux pump inhibitors
AU2024327693A1 (en) * 2023-08-23 2026-04-02 Taxis Pharmaceuticals, Inc. Bacterial efflux pump inhibitors

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL133069C (https=) * 1966-07-29
AR204240A1 (es) 1972-12-13 1975-12-10 Scherico Ltd La preparacion de 2-aminoalcohil-3-fenil-indoles
US3996159A (en) * 1972-12-13 1976-12-07 Schering Corporation Antimicrobial compositions
US4014883A (en) * 1973-09-10 1977-03-29 Hoffmann-La Roche Inc. Indoloquinolines, intermediates and processes
US3978224A (en) 1975-07-01 1976-08-31 Schering Corporation Antimicrobial halo-substituted-2-cyanoethylaminoalkyl-3-phenyl-indoles
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
WO1992004017A1 (en) 1990-09-10 1992-03-19 The Upjohn Company Cis-n-(2-aminocyclohexyl)benzamide and their enantiomers as anticonvulsants
US5663152A (en) 1995-01-19 1997-09-02 Asahi Kasei Kogyo Kabushiki Kaisha Potentiators for aminoglycosides
US6204279B1 (en) 1998-06-03 2001-03-20 Microcide Pharmaceuticals, Inc. Peptidomimetic efflux pump inhibitors
CA2353557A1 (en) 1998-12-04 2000-06-08 Influx, Inc. Inhibitors of multidrug transporters
US6730684B1 (en) 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
US6555569B2 (en) 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
AR034897A1 (es) * 2001-08-07 2004-03-24 Hoffmann La Roche Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
US7829543B2 (en) 2003-01-07 2010-11-09 Paratek Pharmaceuticals, Inc. Substituted polyamines as inhibitors of bacterial efflux pumps
US7994225B2 (en) 2004-03-17 2011-08-09 Rempex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
WO2005113579A1 (en) * 2004-05-21 2005-12-01 Mpex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors and methods of treating bacterial infections
US8143257B2 (en) 2004-11-23 2012-03-27 Ptc Therapeutics, Inc. Substituted phenols as active agents inhibiting VEGF production
US7855228B2 (en) 2005-02-10 2010-12-21 The Board Of Trustees Of The Leland Stamford Junior University Antibiotics targeting MreB
DE102006033109A1 (de) * 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
EP3192788A1 (en) 2006-10-03 2017-07-19 Arbutus Biopharma Corporation Lipid containing formulations
CA2682483A1 (en) * 2007-03-29 2008-10-09 Novartis Ag 3-imidazolyl-indoles for the treatment of proliferative diseases
WO2009110002A1 (en) 2008-03-05 2009-09-11 Council Of Scientific & Industrial Research Novel efflux pump inhibitors
US20100035862A1 (en) * 2008-06-25 2010-02-11 Abbott Laboratories Novel aza-cyclic indole-2-carboxamides and methods of use thereof
EP2303852A4 (en) 2008-06-26 2011-12-28 Glaxosmithkline Llc ACTIVITY INHIBITORS AKT
CA2737038A1 (en) 2008-09-18 2010-03-25 Evotec Ag Amide compounds, compositions and uses thereof
EA201101451A1 (ru) 2009-04-03 2012-03-30 Ачиллион Фармасьютикалз, Инк. Гидрокситиенохинолоны и родственные соединения как противоинфекционные средства
WO2010119984A1 (en) * 2009-04-16 2010-10-21 Banyu Pharmaceutical Co.,Ltd. 3-aryl or heteroaryl-substituted indole derivative
EP2536408A1 (en) 2010-02-16 2012-12-26 Wockhardt Research Centre Efflux pump inhibitors
FR2969150B1 (fr) 2010-12-20 2013-07-26 Centre Nat Rech Scient Nouvelles molecules indoliques demontrant des activites antibacteriennes dans une variete de bacteries a gram-negatif et positif dont des bacteries multidrogues-resistantes
BR112015004666B1 (pt) * 2012-09-07 2022-04-26 Novartis Ag Derivados de indol carboxamida, seu uso, e composição farmacêutica
CA2890748A1 (en) 2012-11-13 2014-05-22 Memorial Sloan-Kettering Cancer Center Indole compounds and their use as antimicrobials
WO2015164482A1 (en) 2014-04-22 2015-10-29 The Johns Hopkins University Inhibitors of drug-resistant mycobacterium tuberculosis
US9926261B2 (en) * 2015-03-10 2018-03-27 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
US9950993B2 (en) 2015-03-13 2018-04-24 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
KR20180011843A (ko) 2015-06-11 2018-02-02 바실리어 파마슈티카 인터내셔널 리미티드 유출-펌프 억제제 및 이의 치료적 용도
US10836706B2 (en) 2016-02-24 2020-11-17 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
US10556854B2 (en) 2016-02-24 2020-02-11 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
US11938114B2 (en) 2017-03-10 2024-03-26 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
CN110770224B (zh) 2017-03-10 2022-11-18 罗格斯新泽西州立大学 作为外排泵抑制剂的吲哚衍生物
WO2018165612A1 (en) 2017-03-10 2018-09-13 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
EP3630109A4 (en) 2017-05-26 2021-03-17 Rutgers, the State University of New Jersey BACTERIAL EFFLUX PUMP INHIBITORS
WO2019005841A1 (en) 2017-06-26 2019-01-03 Rutgers, The State University Of New Jersey THERAPEUTIC COMPOUNDS AND METHODS FOR TREATING INFECTION
US20190031624A1 (en) 2017-07-28 2019-01-31 Rutgers, The State University Of New Jersey Therapeutic compounds and methods to treat infection

Similar Documents

Publication Publication Date Title
JP2020527597A5 (https=)
JP2020510044A5 (https=)
WO2016108045A4 (en) Antimicrobial compounds, compositions and methods
JP7281822B2 (ja) 細菌の排出ポンプ阻害剤
SI2344129T1 (en) AEROSOL FLUOROKINOLONAL FORMULATIONS FOR IMPROVED PHARMACOKINETICS
JP2011530534A5 (https=)
CA2504448A1 (en) Transcription factor modulating compounds and methods of use thereof
JP2017517567A5 (https=)
US20190031624A1 (en) Therapeutic compounds and methods to treat infection
JP2016528257A5 (https=)
US20040204378A1 (en) Substituted polyamines as inhibitors of bacterial efflux pumps
JP2016517851A5 (https=)
EP0936866A4 (en) Compounds, compositions and methods for treating antibiotic-resistant infections
FI3986419T3 (fi) Boorihappojohdannaisia ja niiden terapeuttisia käyttöjä
CN1972695A (zh) 用硼氧基吡啶甲酮治疗或预防哺乳动物皮肤症状或组织症状
JP2009541332A5 (https=)
RU2016107436A (ru) Линейные пептидные антибиотики
TN2022000092A1 (en) Oral complement factor d inhibitors
AU717333B2 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
TN2022000255A1 (en) Pyrrolopyrimidine amines as complement inhibitors
RU2018122505A (ru) Макроциклические антибиотики широкого спектра действия
MX2026001199A (es) Inhibidores del factor d del complemento para administracion oral
JP2015528468A5 (https=)
JP2007522159A5 (https=)
JP2021519265A5 (https=)